tranScrip
Sarah Daniels has a diverse work experience in the pharmaceutical industry. Sarah started their career at SmithKline Beecham in 1989 as Director of Medical Affairs in the CNS Therapeutic Area. Sarah then moved on to ConvaTec in 2000, where they served as the Medical Director for the UK, Ireland, and Scandinavia. In 2005, Sarah joined Roche Products Ltd as the Head of UK Drug Safety and Deputy EU QPPV, and later became the EU Qualified Person for Pharmacovigilance. Currently, they hold the position of Senior Partner at tranScrip and starting in 2023, they will also be the VP Head of Safety Science. Sarah's extensive experience in drug safety, medical affairs, and leadership roles makes their a valuable asset in the pharmaceutical industry.
Sarah Daniels has a degree in Medicine (MBChB) from the University of Ghana.
tranScrip
tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines. We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements. Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.